Announcement

Collapse
No announcement yet.

Lin28

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Lin28

    https://www.sciencedaily.com/release...0430113041.htm

    This sounds very promising! Have you heard of it?
    Scientists have discovered that Lin28 is a major regulator of axon regeneration and a promising therapeutic target for spinal cord injuries.


    Scientists at the Lewis Katz School of Medicine Temple University (PA, USA) have demonstrated that the molecule Lin28 can fuel axon regeneration in mice with spinal cord injury or optic nerve injury. Currently there are no effective treatments for these types of injury. The study, published in Molecular Therapy in April, is the first to establish the regenerative ability of Lin28 upregulation.

    Patients with spinal cord injuries have life-long losses in sensation and motor function due to irreparable damage to axons. Shuxin Li and colleagues at Temple University became interested in Lin28 as a therapeutic target due to its role in stem cell activity.

    “It controls the switch that maintains stem cells or allows them to differentiate and potentially contribute to activities such as axon regeneration,” Li explained. To investigate further, the team used a neuron-specific Thy1 promotor to generate transgenic mice which overexpress Lin28 protein.

    The mouse model revealed that upregulation of Lin28 stimulated long-distance axon regeneration leading to significant improvements in walking and sensory abilities. What is more, overexpression of Lin28, delivered post-injury with adeno-associated virus type 2 vector, also stimulated dramatic axon regeneration.

    “We observed a lot of axon regrowth, which could be very significant clinically, since there currently are no regenerative treatments for spinal cord injury or optic nerve injury,” Li commented.

    The team also demonstrated that upregulation of Lin28 enhances activity of the Akt signaling pathway in mature central nervous system neurons, indicating that Lin28 is critical for regulating growth capacity.

    “Lin28 associates closely with other growth signaling molecules, and we suspect it uses multiple pathways to regulate cell growth,” Li explained. He hopes to further decipher the molecular details of the signaling pathway which could be packaged with Lin28 to aid axon regeneration.

    However, the researchers’ immediate goal is to identify a safe and effective means of getting Lin28 to injured tissues in human patients. This requires developing a vector or carrier system which can be injected systemically and could hone in on injured axons.

    Source: www.templehealth.org/about/news/temple-scientists-regenerate-neurons-in-mice-spinal-cord-injury-optic-nerve-damage

    Last edited by FellowHawkeye; 06-26-2020, 06:59 PM.

  • #2
    I guess my question is why wouldn’t this get published by a bigger journal? Unless it’s simply that there wasn’t any practical motor recovery either observed or studied for.
    C4/5 complete

    Comment


    • #4
      New research by scientists at the Lewis Katz School of Medicine Temple University (LKSOM) shows, however, that gains in functional recovery from these injuries may be possible, thanks to a molecule known as Lin28, which regulates cell growth. In a study published online in the journal Molecular Therapy, the Temple researchers describe the ability of Lin28 -- when expressed above its usual levels -- to fuel axon regrowth in mice with spinal cord injury or optic nerve injury, enabling repair of the body's communication grid.

      "Our findings show that Lin28 is a major regulator of axon regeneration and a promising therapeutic target for central nervous system injuries," explained Shuxin Li, MD, PhD, Professor of Anatomy and Cell Biology and in the Shriners Hospitals Pediatric Research Center at the Lewis Katz School of Medicine at Temple University and senior investigator on the new study. The research is the first to demonstrate the regenerative ability of Lin28 upregulation in the injured spinal cord of animals.

      "We became interested in Lin28 as a target for neuron regeneration because it acts as a gatekeeper of stem cell activity," said Dr. Li. "It controls the switch that maintains stem cells or allows them to differentiate and potentially contribute to activities such as axon regeneration."

      To explore the effects of Lin28 on axon regrowth, Dr. Li and colleagues developed a mouse model in which animals expressed extra Lin28 in some of their tissues. When full-grown, the animals were divided into groups that sustained spinal cord injury or injury to the optic nerve tracts that connect to the retina in the eye.

      Another set of adult mice, with normal Lin28 expression and similar injuries, were given injections of a viral vector (a type of carrier) for Lin28 to examine the molecule's direct effects on tissue repair.

      Extra Lin28 stimulated long-distance axon regeneration in all instances, though the most dramatic effects were observed following post-injury injection of Lin28. In mice with spinal cord injury, Lin28 injection resulted in the growth of axons to more than three millimeters beyond the area of axon damage, while in animals with optic nerve injury, axons regrew the entire length of the optic nerve tract. Evaluation of walking and sensory abilities after Lin28 treatment revealed significant improvements in coordination and sensation.

      "We observed a lot of axon regrowth, which could be very significant clinically, since there currently are no regenerative treatments for spinal cord injury or optic nerve injury," Dr. Li explained.

      One of his goals in the near-term is to identify a safe and effective means of getting Lin28 to injured tissues in human patients. To do so, his team of researchers will need to develop a vector, or carrier system for Lin28, that can be injected systemically and then hone in on injured axons to deliver the therapy directly to multiple populations of damaged neurons.

      Dr. Li further wants to decipher the molecular details of the Lin28 signaling pathway. "Lin28 associates closely with other growth signaling molecules, and we suspect it uses multiple pathways to regulate cell growth," he explained. These other molecules could potentially be packaged along with Lin28 to aid neuron repair.

      Other researchers contributing to the work include Fatima M. Nathan, Yosuke Ohtake, Shuo Wang, Xinpei Jiang, Armin Sami, and Hua Guo, Shriners Hospitals Pediatric Research Center and the Department of Anatomy and Cell Biology at the Lewis Katz School of Medicine; and Feng-Quan Zhou, Department of Orthopaedic Surgery and The Solomon H. Snyder Department of Neuroscience at Johns Hopkins University School of Medicine, Baltimore.

      The research was supported in part by National Institute of Health grants R01NS105961, 1R01NS079432, and 1R01EY024575 and by funding from Shriners Research Foundation.


      Please note it was a study published in Molecular Therapy journal sponsored by NIH

      Comment

      Working...
      X